September 18th to 20th | Las Vegas, NV

ObvioHealth is at Oracle Health Conference 2023

Attending Oracle Health Conference? Connect with us while you’re there to learn more about optimizing patient-centric clinical trials with best-in-class digital tools that drive efficiency and improve data quality to generate stronger evidence.

The Conundrum of Proliferating Data from DCTs

Join hybrid clinical trial experts from ObvioHealth and Oracle as they discuss:

  • How complex data sets—data captured both remotely and on site—can be successfully aggregated and integrated into a single and actionable source of truth.
  • How to solve operational headaches at sites with streamlined workflows.
  • How innovative trial designs can be offered at scale to drive operational efficiencies.

Scott Dixon

Chief Commercial Officer, ObvioHealth

Scott has spent over 25 years bringing integrated commercial and operational planning expertise to life science, pharmaceutical, and healthcare software companies—including Flywheel, Suvoda, Clario, and Oracle. Scott’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app, ObvioGo®.

Florence Mowlem, PhD

Vice President of Science, ObvioHealth

Florence Mowlem, PhD, is an expert eCOA scientist who has spent her career advising and guiding clinical research organizations—including industry powerhouses Medable and Signant Health. At ObvioHealth, Florence will apply her eCOA experience and years of research to further advance the use of health devices in clinical trials and to support the needs of trial participant.

David Blackman

Executive Director of Digital Trials Strategy, Oracle

David Blackman is an experienced digital trials strategist who has spent 20 years leading and incubating cutting-edge solutions for massive technology organizations, including IBM, Lenovo, and PPD. At Oracle, David is responsible for developing differentiating technology and business capabilities that enhance clinical trial research and bring drugs to market faster for Oracle’s clients.

About ObvioHealth

ObvioHealth is a global virtual research organization (VRO) combining the clinical excellence of the best CROs with a pioneering digital health platform to deliver stronger evidence to sites and sponsors. Our tech-enabled team optimizes clinical trials at every touchpoint with a unique combination of three capabilities:  

  • The ObvioGo® DCT platform and app incorporates best-in-class digital instruments, AI, and machine learning to deliver more robust clinical outcomes with less burden on all stakeholders.
  • Our virtual COACH (Clinical Oversight and Coordination Hub) team monitors patient safety and compliance in real time while providing on-demand, personalized support that keeps patients motivated and engaged.
  • Our DCT strategists leverage deep clinical expertise and 6+ years of DCT and hybrid experience to offer the same services as a traditional CRO—optimized for a decentralized environment.